Increased Time in Range with Ultra Rapid Lispro Treatment in Participants with Type 2 Diabetes: PRONTO-Time in Range

被引：0
|
作者：
Timothy S. Bailey
Bruce W. Bode
Qianqian Wang
Alastair W. Knights
Annette M. Chang
机构：
[1] AMCR Institute,
[2] Atlanta Diabetes Associates Hospital,undefined
[3] Eli Lilly and Company,undefined
来源：
Diabetes Therapy | 2023年 / 14卷
关键词：
Continuous glucose monitoring; Time in range; Type 2 diabetes; Ultra rapid lispro;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：883 / 897
页数：14
相关论文
共 50 条
  • [11] Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO-Pump-2
    Warren, Mark
    Bode, Bruce
    Cho, Jang I.
    Liu, Rong
    Tobian, Janet
    Hardy, Thomas
    Chigutsa, Farai
    Phillip, Moshe
    Horowitz, Barry
    Ignaut, Debra
    DIABETES OBESITY & METABOLISM, 2021, 23 (07): : 1552 - 1561
  • [12] The Prognostic Value of Time in Range in Type 2 Diabetes
    Selvin, Elizabeth
    DIABETES CARE, 2021, 44 (02) : 319 - 320
  • [13] Time in Range and Time Below Range in Insulin-Treated Older Adults with Type 2 Diabetes
    Leite, Silmara A. O.
    Silva, Michael
    Lavalle, Ana C. R.
    Bastos, Murilo
    Bertogy, Maria C.
    Vieira, Suelen C.
    Umpierrez, Guillermo E.
    DIABETES, 2022, 71
  • [14] Time above range for predicting the development of type 2 diabetes
    Marco, Alejandra
    Pazos-Couselo, Marcos
    Moreno-Fernandez, Jesus
    Diez-Fernandez, Ana
    Alonso-Sampedro, Manuela
    Fernandez-Merino, Carmen
    Gonzalez-Quintela, Arturo
    Gude, Francisco
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [15] ASSESSING TIME IN RANGE (TIR) WITH POSTPRANDIAL GLUCOSE (PPG)-FOCUSED TITRATION OF ULTRA RAPID LISPRO (URLI) IN PATIENTS (PTS) WITH TYPE 1 DIABETES (T1D)
    Bergenstal, R.
    Bode, B.
    Bhargava, A.
    Wang, Q.
    Chang, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A99 - A99
  • [16] The Optimal "Time in Range" and "Time below Range" are Difficult to Coordinate in Patients with Type 1 Diabetes
    Sekiguchi, Sho
    Yamada, Eijiro
    Nakajima, Yasuyo
    Matsumoto, Shunichi
    Yoshino, Satoshi
    Horiguchi, Kazuhiko
    Ishida, Emi
    Uehara, Ryota
    Okada, Shuichi
    Yamada, Masanobu
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 255 (03): : 221 - 227
  • [17] Ultra rapid lispro (URLi) improves postprandial glucose (PPG) control vs lispro in type 1 diabetes: PRONTO-T1D study
    Dahl, D.
    Cao, D.
    Dellva, M.
    Tobian, J. A.
    Miura, J.
    Klaff, L.
    Bue-Vallesky, J. M.
    DIABETOLOGIA, 2019, 62 : S93 - S93
  • [18] Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D
    Blevins, Thomas
    Zhang, Qianyi
    Frias, Juan P.
    Jinnouchi, Hideaki
    Chang, Annette M.
    DIABETES CARE, 2020, 43 (12) : 2991 - 2998
  • [19] Ultra Rapid Lispro (URLi) Improves Postprandial Glucose (PPG) Control and Time in Range (TIR) in T1D Compared with Humalog (Lispro): PRONTO-T1D Continuous Glucose Monitoring (CGM) Substudy
    Bode, Bruce W.
    Cao, Dachuang
    Liu, Rong
    Hardy, Thomas
    Bue-Valleskey, Juliana M.
    DIABETES, 2019, 68
  • [20] Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients With Type 2 Diabetes: PRONTO-T2D Subpopulation Analysis
    Jinnouchi, Hideaki
    Imori, Makoto
    Nishiyama, Hiroshi
    Imaoka, Takeshi
    DIABETES THERAPY, 2020, 11 (09) : 2075 - 2088
12345